It has been established that two distinct transgenic models of breast cancer, MMTV-NeuYD and MMTV-Wnt1 reflect different forms of human breast cancer pathophysiology characterized by early vs late stage morphology and differentiation markers. This evidence concerns the gene WNT1 and breast carcinoma.